higher incidence of cardiovascular dysfunction, and greater variability in haemodynamic status during resuscitation; furthermore, these changes can occur rapidly. 3 Early detection of cardiovascular insufficiency in high-risk patients may reduce morbidity and mortality, by guiding the timely application of appropriate therapy. 4 5 However, an accurate assessment of cardiovascular status requires advanced haemodynamic monitoring, including measurement of cardiac output (CO). 6 7 This is reinforced by the finding that CO cannot be estimated clinically, and deleterious changes in CO can precede changes in other haemodynamic variables. 8 9 Although a variety of techniques for CO measurement are available in paediatric patients, there is growing interest in continuous methodologies based upon arterial pulse wave analysis. These have the obvious advantage of utilizing a preexisting arterial line; in addition, not all require external calibration. 10 However, concerns have been raised about the accuracy of these methods, particularly during periods of haemodynamic instability. 11 12 Pressure recording analytical method (PRAM) is a relatively novel arterial pulse wave method of CO measurement. 13 In contrast to other pulse contour techniques, PRAM is based primarily upon detailed morphological analysis of the pressure waveform, including identification of pulsatile and non-pulsatile systolic pressure-time areas together with an estimation of vascular impedance. There are several adult and animal validation studies of PRAM; however, there is paucity of literature regarding its use in paediatrics.
track changes in CO after routine therapeutic manoeuvres, via the use of polar plots. 17 
Methods
This prospective, single centre, observational study was conducted within a 20-bed multi-disciplinary paediatric intensive care unit (PICU). The study was approved by the regional ethics committee (South East London REC2, 10/H0802/62) and written informed consent was obtained from all parents or legal guardians.
Forty-eight, mechanically ventilated children (32 males) were enrolled during September 2010 to October 2011, of whom 78% were also receiving inotropic support. The median (inter-quartile range) age and weight were 17.0 (4.5 -47.3) months and 10.7 (5.5 -15) kg, respectively. The majority of patients were admitted after cardiac surgery (Table 1) , and data were collected within the first 24 h after admission. Inclusion criteria included the presence of arterial and central venous lines. Children with significant valvular regurgitation, extreme haemodynamic instability, large anatomical shunts, or arrhythmias were excluded from the study. 
Transpulmonary UD technique

Study protocol
Measurements were made as soon as possible after patients were admitted to the PICU (all within 24 h of admission). Baseline patient characteristic and physiological data were collected at the time of CO measurement. The sequence of CO measurements is shown in Figure 1 .
Paired UD and PRAM measurements were made as follows: two consecutive UD measurements were made, and the dilution curves inspected. If the shape of the injection or dilution curves were unsatisfactory (Fig. 2) , or if the variation between the two measurements was .20%, a third measurement was obtained. The readings were than averaged. This process typically took 3-5 min. PRAM measurements could not be obtained exactly at the same time, as the UD measurements required interruption of the arterial line. Thus, we averaged the continuous CO from PRAM for 3 min before and after the time corresponding to the UD measurements. Thus, a complete set of comparative measurements took 10 min. Heart rate was monitored continuously and non-invasive arterial pressure measurement performed every minute to ensure haemodynamic stability during this 10 min period.
We performed repeated comparisons (as above) when patients received therapies likely to augment CO, such as fluid bolus administration or initiation of vasoactive medications. By taking repeated measurements on patients, we were also able to assess the ability of PRAM to track changes in CO.
Statistical methods
Values for CO are reported as mean (SD). Repeatability of each technique is reported via the coefficient of variation (standard deviation/mean, expressed as a percentage). Agreement between the two methods for measuring absolute values of CO was quantified using the Bland -Altman analysis. 24 The bias was defined as the mean difference between the two methods (PRAM minus UD). Limits of agreement were calculated as the mean bias (1.96 SD of the bias), adjusted for multiple measurements per patient. 24 The percentage error was calculated as (1.96 SD of the bias/mean of the reference 25 If we stipulate that PRAM should be at least as accurate as UD, we thus expect an upper limit for the combined limits of agreement of +18%. Agreement between the two methods for tracking changes in CO (DCO) was quantified using polar plots. 17 This methodology is illustrated briefly in Figure 3 , and in more detail elsewhere. 26 After exclusion of data points representing small changes in CO (i.e. vectors ,10% of the mean CO, equating to changes of ,0.2 litre min 21 in our study), we quantified tracking in two ways. First, acceptable calibration was defined as an angular mean bias of less than +58. 17 Secondly, we reported the percentage of data points lying within radial limits of +308 from the polar axis. This area should contain more than 95% of the data points if the test method is able to track changes in CO accurately (based upon a reference method precision of 20%). 17 Statistical analyses were performed using Stata v11 (StataCorp., TX, USA), Microsoft Office Excel 2007, and polar plots were created using Sigmaplot 8.02 for Windows (Systat Software, Inc., San Jose, CA, USA).
Results
A total of 210 paired measurements using UD and PRAM were compared in 48 children. Six children had two comparisons, three had three comparisons, 21 children had four, and 18 patients had between five and eight comparisons. No child had more than eight comparisons. Repeated measurements on the same patient were made for the following reasons: fluid bolus (84%), administration of a vasoactive agent (8%), and extubation (8%).
The mean CO with UD was 1. readings: this gave a mean (SD) coefficient of variation of 9.1 (6.2%)]. The Bland -Altman analysis (Fig. 4) gave the mean bias of 0.02 litre min 21 , with wide limits of agreement of +2.21 litre min 21 and a percentage error of 116%. The Bland -Altman plot suggested the presence of a systematic error, with PRAM over-reading at lower CO and under-reading at high CO (Fig. 4, r¼0 .69).
Since CO is a measure of total flow, which is influenced by patient size, we repeated the analysis after normalization to body surface area (i.e. cardiac index) to see if the error was influenced by high or low flow states. Here, the mean bias was 0.95 litre min 21 (Fig. 5) . This suggested a different type of systematic error, heteroscedasticity, which persisted even after log transformation (data not shown).
The polar plots demonstrated a poor ability of PRAM to track changes in CO (Fig. 6 ). On average, PRAM followed the change in CO (mean angular deviation from polar axis of 25.48); however, only 36.6% of measurements fell within the polar limits of +308.
Discussion
Our results demonstrate poor agreement between PRAM and UD, both in terms of measuring absolute CO (percentage error 116%) and tracking changes in CO (36.6% of measurements falling within polar limits). Our findings are at odds with the other two paediatric studies using PRAM. Calamandrei and colleagues 14 There are a number of potential reasons for the discrepancy between our results and these studies, including the If both methods concur exactly, the vector representing the change will lie on the line of identity. In example 1, the test method is over-reading the increase in CO compared with the reference method by 1 litre min 21 . The vector representing this relationship will have an angle u 1 that has a positive deviation from the line of identity. This is represented on the polar plot (B), whereby the angle u 1 is represented relative to the zero degree axis, and the size of the vector is relative to the hypotenuse of the change in CO from the two methods. For a decrease in CO, as seen in example 2, where the test method also overestimates the negative change in CO (u 2 ), the corresponding polar plot vector will be relative to the 1808 axis (B). Good concurrence is represented by 95% of the points lying within an absolute deviation of +308 from the polar axis (0 -1808, blue dashed lines). It is also customary to exclude small changes in CO, identified as those lying within the circular zone of exclusion. Typically, this boundary represents changes in CO that are ,10% of the mean change (blue shaded circle). Here example 1 shows adequate concurrence (within the +308 boundary from the polar axis), whereas example 2 does not.
use of different reference methods for CO, case mix, and different cardiovascular profiles.
Reference methods
We used UD as the reference method, which, although a novel technique, has been shown to be accurate in small patients. In a piglet model using pulmonary artery flow probes as the reference method (a true gold standard), de Boode and colleagues 21 showed that the percentage error for UD was 27% (mean CO 0.96 litre min 21 ). Similar accuracy (percentage error 24%) was shown in another swine model, using pulmonary artery thermodilution as the reference. 27 In 28 children undergoing cardiac catheterization, Crittendon and colleagues 19 compared UD with pulmonary artery thermodilution, again yielding a similar percentage error of 25.4%. We have no reason to suspect that UD is any less accurate in our study; this is further supported by our low coefficient of variation (5.7%).
Case mix and cardiovascular profiles
Our patient population contained potentially important differences to both prior paediatric studies. Ours was comprised primarily of children post-cardiac bypass, a group not represented in either previous study. 14 with the percentage error of 34% at the baseline. Similar to our results, they also demonstrated PRAM to be unable to accurately track changes in CO (concordance rate of 60%). Our study has several possible limitations. First, PRAM CO was not measured precisely at the same time as UD. Instead, PRAM readings were averaged 3 min before and after the time corresponding to the UD measurement. This was because the arterial line connection to the PRAM was interrupted during measurement of CO using UD. However, we believe that this is unlikely to have compromised our results due to unexpected haemodynamic instability, as the entire measurement period was brief (typically ,10 min), PRAM readings were averaged pre-and post-UD, and the average coefficient of variation for PRAM from each measurement period was 9.1 (6.2%), which infers haemodynamic stability. The coefficient of variation for UD was 5.7 (6%), which is in agreement with another study. 30 Secondly, we did not measure the arterial line dampening coefficient while using PRAM. This represents a potentially important limitation, as both under-and over-dampening have recently been shown to adversely affect the ability of PRAM to estimate CO. 31 However, we are currently undertaking a follow on study evaluating factors that may affect the accuracy of the PRAM algorithm, which includes measurement of the dampening coefficient. A final point to consider is that there may be inherent limitations with the use of continuous pulse contour methods unique to the paediatric population. These methods typically estimate stroke volume from the arterial pressure waveform taking into consideration vascular properties such as impedance, compliance, and peripheral vascular resistance. However, paediatric studies have shown that these vascular properties may be age-dependent, and can change rapidly during the course of illness. 3 32 33 Furthermore, measuring small values in tiny children may push these devices towards their limits of accuracy.
Conclusion
We found an unacceptable lack of agreement between UD and PRAM for measurement of paediatric CO in critically ill patients. PRAM was also not able to track changes in CO accurately when compared with the UD method. Hence, we do not recommend the use of PRAM for measuring CO in critically ill children with the current algorithm.
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